Research and innovation in diabetes and obesity therapeutics

Type 2 Diabetes and Obesity Therapeutics

This report was published by the Biotechnology Innovation Organization (BIO) in early 2019, providing facts about the latest developments in the area of diabetes and obesity therapeutics. This report is the third in a series about the innovation landscape of highly prevalent, chronic diseases.
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!